comparemela.com

Latest Breaking News On - News ratings for centessa pharmaceuticals daily - Page 4 : comparemela.com

Centessa Pharmaceuticals (NASDAQ:CNTA) Trading Up 7.2%

Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report) shares traded up 7.2% during mid-day trading on Thursday . The company traded as high as $11.32 and last traded at $11.15. 50,347 shares traded hands during mid-day trading, a decline of 91% from the average session volume of 537,237 shares. The stock had previously closed at […]

China
Harris-rotman
Institutional-trading-of-centessa-pharmaceuticals
News-ratings-for-centessa-pharmaceuticals-daily
Manufacturers-life-insurance-company
Securities-exchange-commission
Jefferies-financial-group
Centessa-pharmaceuticals
China-universal-asset-management-co
Geode-capital-management
Centessa-pharmaceuticals-price-performance
Blackrock-inc

Centessa Pharmaceuticals (NASDAQ:CNTA) Shares Down 7.4%

Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report)’s share price traded down 7.4% on Tuesday . The stock traded as low as $10.78 and last traded at $10.88. 128,920 shares were traded during mid-day trading, a decline of 76% from the average session volume of 536,692 shares. The stock had previously closed at $11.75. Wall […]

China
Harris-rotman
Manufacturers-life-insurance-company
Hedge-funds-weigh-in-on-centessa-pharmaceuticals
China-universal-asset-management-co
Jefferies-financial-group
Morgan-stanley
Securities-exchange-commission
Centessa-pharmaceuticals
Blackrock-inc
Geode-capital-management
Centessa-pharmaceuticals-stock-down

Centessa Pharmaceuticals plc (NASDAQ:CNTA) Given Average Rating of "Moderate Buy" by Brokerages

Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the eight analysts that are presently covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average […]

China
Harris-rotman
Geode-capital-management
Jefferies-financial-group
Manufacturers-life-insurance-company
Centessa-pharmaceuticals-price-performance
Analyst-recommendations-for-centessa-pharmaceuticals
China-universal-asset-management-co
News-ratings-for-centessa-pharmaceuticals-daily
Centessa-pharmaceuticals
Nasdaq
Hedge-funds-weigh-in-on-centessa-pharmaceuticals

Short Interest in Centessa Pharmaceuticals plc (NASDAQ:CNTA) Increases By 14.7%

Short Interest in Centessa Pharmaceuticals plc (NASDAQ:CNTA) Increases By 14.7%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

China
News-ratings-for-centessa-pharmaceuticals-daily
Centessa-pharmaceuticals-stock-down
China-universal-asset-management-co
Susquehanna-international-group
Prelude-capital-management
Centessa-pharmaceuticals
Nasdaq
Jpmorgan-chase-co
Barclays-plc
Institutional-trading-of-centessa-pharmaceuticals

Centessa Pharmaceuticals plc (NASDAQ:CNTA) Short Interest Update

Centessa Pharmaceuticals plc (NASDAQ:CNTA – Get Free Report) was the target of a large decrease in short interest in the month of December. As of December 31st, there was short interest totalling 1,090,000 shares, a decrease of 42.3% from the December 15th total of 1,890,000 shares. Approximately 1.9% of the shares of the stock are […]

Manufacturers-life-insurance-company
Affinity-asset-advisors
Centessa-pharmaceuticals
News-ratings-for-centessa-pharmaceuticals-daily
Centessa-pharmaceuticals-company-profile
Jefferies-financial-group
Centessa-pharmaceuticals-trading-down
Institutional-investors-weigh-in-on-centessa-pharmaceuticals
Morgan-stanley
Nasdaq
Rathbones-group

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.